文献速递胃肠外科围术期管理与 ERAS

术前胃内球囊不能降低减重手术早期术后并发症:一项随机对照临床研究

Preoperative intragastric balloon in morbid obesity is unable to decrease early postoperative morbidity of bariatric surgery (sleeve gastrectomy and gastric bypass): a clinical assay.
PubMed 文献 · Surg Endosc · 2019-08-09

该前瞻性随机研究纳入66例重度肥胖患者,比较术前6个月内放置胃内球囊(B组)与对照组(C组)对袖状胃切除或胃旁路术后结局的影响。结果显示,球囊组术前减重更多(16.2 kg vs 4.7 kg),但术后并发症发生率(25% vs 29.5%,p=0.689)、住院时间(7天 vs 7天,p=0.937)及再手术率均无显著差异;球囊放置成本超过4000欧元。

要点

  • 术前胃内球囊未降低减重术后并发症、住院时间或再手术率。
  • 球囊组术前减重及BMI下降显著优于对照组(p<0.001)。
  • 球囊放置成本高(>4000欧元/例),需权衡其附加费用。

核心结论

  • 术前胃内球囊不能减少减重手术(袖状胃切除或胃旁路)的术后并发症、住院时间或再手术率。
  • 球囊较饮食方案实现更高减重,但其附加成本需予以考虑。

研究设计与样本

  • 前瞻性随机对照临床研究,纳入66例重度肥胖患者,65.6%为女性,69.6%接受胃旁路术。
  • B组在术前6个月内放置胃内球囊,C组为对照组。

主要发现

  • B组术前平均体重下降16.2 kg(SD 9.84),C组4.7 kg(SD 8.70);%EWL分别为23.6%与4.7%(p<0.001);BMI下降分别为6.04与1(p<0.001)。
  • 术后并发症发生率B组25%,C组29.5%(p=0.689);预防术后并发症的NNT为23例。
  • 住院时间B组7天(p25-75:5-8),C组7天(p25-75:5-9),p=0.937。
  • B组中重度术后不良事件发生率为54.5%(12.5%),C组为82.6%(23.5%),p=0.111。
  • 胃内球囊治疗失败率为34.4%;每个球囊放置成本超过4000欧元。

临床怎么用

  • 不应常规以术前胃内球囊替代饮食减重来期望降低减重手术并发症。
  • 对选择球囊患者应告知其较高失败率(34.4%)及附加费用。

局限性

  • 样本量较小(66例),可能不足以检测并发症差异。
  • 原文未报告盲法、随访时长及再手术率具体数值。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

INTRODUCTION: There are few studies that investigate the usefulness of the preoperative intragastric balloon (IGB). This study will evaluate if pre-surgical weight loss with IGB reduces morbidity and mortality after surgery. METHOD: Prospective randomised study of patients with morbid obesity treated with gastric bypass or vertical gastrectomy, with two arms: the balloon arm (B-arm), where an IGB was inserted within the 6 months before surgery, and the control arm (C-arm). RESULTS: The study included 66 patients: 65.6% women, 69.6% with bypass. Age: 43 years (SD 10.2) B-arm and 42.6 years (SD 9.2) in the C-arm. We found 34.4% therapeutic failures in IGB. The mean body weight loss, %EWL and BMI reduction before surgery was 16.2 kg (SD 9.84) B-arm versus 4.7 (SD 8.70) in the C-arm, 23.6% versus 4.7% (p < 0.001) and 6.04 versus 1 (p < 0.001), respectively. The hospital stay was 7 days (p25-75: 5-8) B-arm and 7 days (p25-75: 5-9) in the C-arm (p = 0.937). Post-surgical morbidity with IGB was 25% versus 29.5% in the C-arm, p = 0.689. The number needed to treat (NNT) to prevent of post-surgical morbidity was 23 patients. The B-arm presented 54.5% moderate-severe post-surgical adverse events (12.5%) versus 82.6% in the C-arm (23.5%), p = 0.111. The cost of placing a balloon was more than 4000 Euros each. CONCLUSIONS: The preoperative balloon does not achieve a reduction in the post-surgical morbidity, nor does it reduce the hospital stay or rate of re-operations. The balloon achieves a higher weight loss result when compared to a diet programme, its added cost must also be given due consideration. TRAIL REGISTRY: This study has been registered on ClinicalTrials.gov with the Identifier: NCT01998243 (November 28, 2013).

来源:Surg Endosc,查看原文。版权归原作者所有。

引用

  1. Vicente Martin C, Rabago Torre LR, Castillo Herrera LA, et al. Preoperative intragastric balloon in morbid obesity is unable to decrease early postoperative morbidity of bariatric surgery (sleeve gastrectomy and gastric bypass): a clinical assay. Surg Endosc. 2019. PMID: 31399943. doi:10.1007/s00464-019-07061-w

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。